drugset / Trial / NCT03027674

Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud

NCT03027674

Phase 0 Completed 10 enrolled Pontificia Universidad Catolica de Chile
RandomizedParallel-groupTriple-blindTreatment

Summary

Objective: To compare the efficacy of topical 10% nifedipine versus 5% sildenafil in patients with secondary Raynaud's phenomenon (RP). Methods: A randomized, double-blind, placebo-controlled pilot study took place in 10 patients with secondary RP. Topical 10% nifedipine on one hand and 5% sildenafil on the other hand were applied. The thumbs didn't receive any cream and served as a control group. The primary outcome was the improvement of blood flow and vessel diameter of the digital arteries measured by high frequency color Doppler ultrasound before and 1 hour after treatment.

Timeline

Start
2016-08
Primary completion
2016-08
Completion
2016-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Nifedipine Other / unclassified 10 % Topical
Subject Nifedipine Other / unclassified 5 g Topical
Comparator Sildenafil Unknown 5 % Topical
Comparator Sildenafil Unknown 5 g Topical